Low/Intermediate Risk-1 MDS
1 clinical trials · Condition
◉ Watch Low/Intermediate Risk-1 MDS
| Record | Firm | Date |
|---|---|---|
| A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia (NCT04324060) | Peking Union Medical College Hospital | 2020-03-01 |
Track Low/Intermediate Risk-1 MDS automatically
Every clearance here is in the API, with alerts when new ones post.